- Sulphur Ointment
- Benzyl Benzoate Lotion
- Lindane Lotion
- Crotamiton Cream
- Permethrin Cream
Â Scabies Treatment Market size is expected to be USD 212.24 million in 2022 to more than USD 322 million by 2028, growing at a high CAGR of 5.1% from 2022 to 2028. Scabies is a contagious skin infection caused by Sarcoptes scabiei. Pimple-like rashes and severe itchiness are the symptoms associated with scabies. The mode of transmission of scabies is skin-to-skin contact. The common site of infestation include armpits, around fingernails, inner elbow, in between fingers, and soles of feet among others. Scabies can be treated with antibiotics, antihistamines, and steroid creams. The Scabies Treatment Market report gives a comprehensive outlook across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on the global market gives historical, current, and future market sizes (US$ Bn) of drug type (sulfur ointment, benzyl benzoate lotion, lindane lotion, crotamiton cream, permethrin cream, others), route of administration (oral, topical), distribution channel and geographic regions. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities, and possible challenges to the key stakeholders operating in the market. In addition, the market report includes a regulatory scenario and competition analysis with a vividly illustrated competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the report include suppliers, manufacturers, marketers, policymakers engaged in manufacturing and supply.
Fastest Growing Market
Improper hygienic conditions and environmental factors are the key factor to increase the number of person affected to scabies. Moreover, low cost of drugs, increase in R&D for the innovation of newer drugs, rapid escalation of global population with poor hygienic, and increase in healthcare expenditure are anticipated to fuel the scabies treatment market. Moreover, homecare remedies for the scabies treatment and limited number of advanced therapeutics are expected to restrain the growth of scabies treatment market.
The scabies treatment market is projected to expand at a CAGR of 5.1% during the forecast period
Merck & Co. Inc. (U.S.), Renaissance Pharma, Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), GlaxoSmithKline plc (U.K.), Unichem Laboratories Ltd. (India), Zydus Cadila (India), Prestium Pharma, Inc. (U.S.)
North America is the fastest-growing region for the home infusion therapy devices market